Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2026 Earnings Call Transcript May 14, 2026
Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $0.01.
Operator: Good afternoon, and welcome to Sangamo Therapeutics First Quarter 2026 Teleconference Call. Please be advised that today’s conference is being recorded. I would now like to turn the conference over to your speaker today, Louise Wilkie, Head of Investor Relations and Corporate...
